Siprolip is a drug used to reduce high blood lipids (cholesterol) from the class of cholesterol synthesis enzyme inhibitor. The active substance of Siprolip, simvastatin, reduces cholesterol production in the liver. For simvastatin has been shown that in patients at high risk for coronary heart disease, it reduces the risk of suffering a heart attack or stroke.
Siprolip is used:
in addition of a diet in:
• patients with hypercholesterolemia (primary or mixed hyperlipidemia) when diet and other measures such as physical training or weight loss alone are not sufficient;
• patients with homozygous familial hypercholesterolemia, along with other treatments or if such are not suitable; for the prevention of cardiovascular diseases:
• in patients whose cholesterol levels in the blood are normal or elevated, with established atherosclerotic cardiovascular disease or diabetes, along with other preventive measures.